Clinical Practice Guidelines: Management of hepatocellular carcinoma, Journal of Hepatology, vol.69, pp.182-236, 2018. ,
,
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.29, pp.238-55, 2018. ,
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial, The Lancet Oncology, vol.18, issue.17, pp.30683-30689, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01727346
Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma, Journal of Clinical Oncology, vol.36, pp.1913-1934, 2018. ,
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma, Journal of Hepatology, vol.71, pp.1164-74, 2019. ,
,
Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC, Lancet Oncol, vol.19, issue.18, p.30024, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01709600
,
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma, Gastroenterology, vol.151, pp.1155-1163, 2016. ,
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy, Hepatology, vol.60, pp.192-201, 2014. ,
,
Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization, J Vasc Interv Radiol, vol.26, pp.1472-1480, 2015. ,
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma, Cardiovasc Intervent Radiol, vol.40, pp.1213-1235, 2017. ,
Fast technetium-99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry, Med Phys, vol.46, pp.345-55, 2019. ,
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results, J Nucl Med, vol.53, pp.255-63, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00866987
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres, Q J Nucl Med Mol Imaging, vol.56, pp.503-511, 2012. ,
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis, J Nucl Med, vol.56, pp.339-385, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01128116
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group, European Journal of Nuclear Medicine and Molecular Imaging, vol.46, pp.1695-704, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02152867
,
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma, Eur J Nucl Med Mol Imaging, vol.45, pp.392-401, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01709935